Cargando…
Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified
Metabolic surgery has been studied in the last decades as an effective and safe treatment for type 2 diabetes (T2D), and randomized controlled trials generally found surgery superior when compared with medical treatment. In 2016, the DSS-II Joint Statement recognized the importance of metabolic surg...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491361/ https://www.ncbi.nlm.nih.gov/pubmed/32930887 http://dx.doi.org/10.1007/s00592-020-01603-8 |
_version_ | 1783582205543448576 |
---|---|
author | Halpern, Bruno Mancini, Marcio C. |
author_facet | Halpern, Bruno Mancini, Marcio C. |
author_sort | Halpern, Bruno |
collection | PubMed |
description | Metabolic surgery has been studied in the last decades as an effective and safe treatment for type 2 diabetes (T2D), and randomized controlled trials generally found surgery superior when compared with medical treatment. In 2016, the DSS-II Joint Statement recognized the importance of metabolic surgery in the treatment of T2D and urged clinicians to discuss, recommend, or at least consider this procedure for their patients. Diabetes societies also cogitate metabolic surgery as an option for T2D patients in their guidelines. However, there are some differences in recommendations that could lead a careful reader to some confusion. This was potentialized in a recent document published by the same DSS-II group concerning prioritization for surgery after the COVID-19 pandemic, in which the criteria suggested for an expedited recommendation that is not exactly evidence-based, and collided substantially with several clinical guidelines worldwide, especially with regard to secondary prevention of cardiovascular disease. A more harmonious discussion and unified guidelines between clinicians and surgeons are needed in order to provide the same message for those who read different articles. |
format | Online Article Text |
id | pubmed-7491361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-74913612020-09-15 Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified Halpern, Bruno Mancini, Marcio C. Acta Diabetol Perspectives Metabolic surgery has been studied in the last decades as an effective and safe treatment for type 2 diabetes (T2D), and randomized controlled trials generally found surgery superior when compared with medical treatment. In 2016, the DSS-II Joint Statement recognized the importance of metabolic surgery in the treatment of T2D and urged clinicians to discuss, recommend, or at least consider this procedure for their patients. Diabetes societies also cogitate metabolic surgery as an option for T2D patients in their guidelines. However, there are some differences in recommendations that could lead a careful reader to some confusion. This was potentialized in a recent document published by the same DSS-II group concerning prioritization for surgery after the COVID-19 pandemic, in which the criteria suggested for an expedited recommendation that is not exactly evidence-based, and collided substantially with several clinical guidelines worldwide, especially with regard to secondary prevention of cardiovascular disease. A more harmonious discussion and unified guidelines between clinicians and surgeons are needed in order to provide the same message for those who read different articles. Springer Milan 2020-09-15 2021 /pmc/articles/PMC7491361/ /pubmed/32930887 http://dx.doi.org/10.1007/s00592-020-01603-8 Text en © Springer-Verlag Italia S.r.l., part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Perspectives Halpern, Bruno Mancini, Marcio C. Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title_full | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title_fullStr | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title_full_unstemmed | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title_short | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
title_sort | type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491361/ https://www.ncbi.nlm.nih.gov/pubmed/32930887 http://dx.doi.org/10.1007/s00592-020-01603-8 |
work_keys_str_mv | AT halpernbruno type2diabetesandmetabolicsurgeryguidelinesandrecommendationsshouldurgentlybeunified AT mancinimarcioc type2diabetesandmetabolicsurgeryguidelinesandrecommendationsshouldurgentlybeunified |